# Gender Difference in NET Activation in Patients With Congenital Heart Disease and Heart Failure

> **NCT05263843** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 150 (estimated)

## Conditions studied

- Congenital Heart Disease
- Heart Failure
- Gender

## Interventions

- **DIAGNOSTIC_TEST:** Biological markers of myocardial fibrosis

## Key facts

- **NCT ID:** NCT05263843
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-22
- **Primary completion:** 2025-02-23
- **Final completion:** 2025-02-23
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-01-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05263843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05263843, "Gender Difference in NET Activation in Patients With Congenital Heart Disease and Heart Failure". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05263843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*